Zenas BioPharma, Inc.
ZBIO
$32.53
-$0.52-1.57%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 135.34% | 129.59% | -2.16% | -24.80% | 48.58% |
| Total Receivables | -38.46% | -35.29% | -40.00% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 145.23% | 218.11% | 121.03% | -36.12% | 15.97% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 134.67% | 129.75% | -1.34% | -24.67% | 47.72% |
|
|
|||||
| Total Current Assets | 134.67% | 129.75% | -1.34% | -24.67% | 47.72% |
| Net Property, Plant & Equipment | -21.20% | -12.38% | 16.74% | 57.25% | 51.70% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 38.08% | 17.22% | 7.41% | 51.52% | 10.81% |
| Total Assets | 139.42% | 124.01% | 3.70% | -20.18% | 46.58% |
|
|
|||||
| Total Accounts Payable | -4.31% | -55.32% | -58.50% | -57.27% | -5.11% |
| Total Accrued Expenses | 28.94% | 81.06% | 38.67% | 58.98% | 49.77% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.78% | 14.21% | 42.04% | 60.94% | 60.53% |
| Total Finance Division Other Current Liabilities | -- | 2,260.00% | -44.08% | -- | -- |
| Total Other Current Liabilities | -- | 2,260.00% | -44.08% | -- | -- |
| Total Current Liabilities | 23.62% | 24.48% | 9.35% | 19.15% | 36.15% |
|
|
|||||
| Total Current Liabilities | 23.62% | 24.48% | 9.35% | 19.15% | 36.15% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -89.77% | -75.71% | -3.21% | -- | 1,435.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 750.36% | 732.88% | 146.04% | 185.45% | 36.65% |
|
|
|||||
| Common Stock & APIC | 69.14% | 67.67% | 43.98% | 3.89% | 9,673.88% |
| Retained Earnings | -102.37% | -100.99% | -97.51% | -56.72% | -59.76% |
| Treasury Stock & Other | -1,113.83% | -367.38% | -132.99% | -227.78% | -190.38% |
| Total Common Equity | 3.12% | 18.12% | -22.50% | -45.35% | 182.98% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.12% | 18.12% | -22.50% | -45.35% | 182.98% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.12% | 18.12% | -22.50% | -45.35% | 48.99% |
|
|
|||||